Regeneron Pharmaceuticals, Inc.
ISIN US75886F1075
|WKN 881535
Market cap (in EUR)
55.533,68 mln
Country
Stati Uniti
Sector
Servizi sanitari
Dividend yield
0,15%
Overview
Quote
Trade with your broker
Description
Regeneron Pharmaceuticals, Inc. è un'azienda di biotecnologie, che si occupa di scoperta, invenzione, sviluppo, produzione e commercializzazione di farmaci. Il suo portafoglio prodotti comprende i seguenti marchi: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST e ZALTRAP. L'azienda accelera il processo tradizionale di sviluppo dei farmaci attraverso le sue tecnologie proprietarie VelociSuite, come VelocImmune, che utilizza topi geneticamente umanizzati unici per produrre anticorpi ottimizzati completamente umani e anticorpi bispecifici. L'azienda è stata fondata da Alferd G. Gilman, Leonard S. Schleifer ed Eric M. Shooter l'8 gennaio 1988 e ha sede a Tarrytown, NY.
Servizi sanitari Biofarmaci Biofarmaci specifici del sistema Stati Uniti
Financials
Key metrics
| Market capitalisation, EUR | 55.533,68 mln |
| EPS, EUR | 36,59 |
| P/B ratio | 2,11 |
| P/E ratio | 14,62 |
| Dividend yield | 0,15% |
Income statement (2024)
| Revenue, EUR | 13.129,39 mln |
| Net income, EUR | 4.079,34 mln |
| Profit margin | 31,07% |
What ETF is Regeneron Pharmaceuticals, Inc. in?
There are 374 ETFs which contain Regeneron Pharmaceuticals, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Regeneron Pharmaceuticals, Inc. is the VanEck Genomics and Healthcare Innovators UCITS ETF A.
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
Select your savings amount:
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
 | 0.00€ | 0.00€ | View offer* | |
 | 0.00€ | 0.00€ | View offer* |
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
Performance
Returns overview
| YTD | -24.26% |
| 1 month | +1.81% |
| 3 months | -20.32% |
| 6 months | -31.21% |
| 1 year | -43.83% |
| 3 years | -17.68% |
| 5 years | -2.81% |
| Since inception (MAX) | +38.48% |
| 2024 | -15.31% |
| 2023 | +18.11% |
| 2022 | +17.80% |
| 2021 | +45.43% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 32.05% |
| Volatility 3 years | 29.64% |
| Volatility 5 years | 28.97% |
| Return per risk 1 year | -1.37 |
| Return per risk 3 years | -0.21 |
| Return per risk 5 years | -0.02 |
| Maximum drawdown 1 year | -56.57% |
| Maximum drawdown 3 years | -56.57% |
| Maximum drawdown 5 years | -56.57% |
| Maximum drawdown since inception | -56.57% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
